International Diabetes CenterDisclosures
Dr. Cuddihy is a board member or is a member of the advisory panel for the following companies: Abbott, Bayer, CeQur, Eli Lilly, Novo Nordisk, Roche. Dr. Cuddihy has received research support from the following companies: Abbott, Amylin Pharmaceuticals, Bayer, Daiichi-Sankyo, Dexcom, Edwards Lifesciences, Eli Lilly, Intarcia, Johnson & Johnson, MannKind, Medtronic, MiniMed, Merck, Novo Nordisk, Quotient Diagnostics, ResMes, Roche, sanofi-aventis, Takeda Pharmaceuticals North America. Dr. Cuddihy has received other compensation from: Eli Lilly and Company, Lifescan, Merck, Novartis Pharmaceuticals Corporation, sanofi-aventis. All monies have been paid directly to the International Diabetes Center.
You need to be logged in to save this episode to a playlist.
You must be logged in to display playlists.